menu
    • menu

    Company profile for ModeX Therapeutics

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ModeX is dedicated to developing next-generation multispecific biologics for cancers and infectious diseases. ModeX’s platforms unite the power of multiple biologics in a single molecule to create multispecific antibodies and vaccines with unprecedented versatility and potency against complex diseases. In May 2022, we merged with OPKO Health to begin a major new phase for both companies as a united entity with a shared visio...
    ModeX is dedicated to developing next-generation multispecific biologics for cancers and infectious diseases. ModeX’s platforms unite the power of multiple biologics in a single molecule to create multispecific antibodies and vaccines with unprecedented versatility and potency against complex diseases. In May 2022, we merged with OPKO Health to begin a major new phase for both companies as a united entity with a shared vision for transforming medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ModeX TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    22 Strathmore Road Natick, MA 01760
    Telephone
    Telephone
    +1 8572339936
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.modextherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/modex-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OPKO Health's Modex Therapeutics Begins MDX2301 Trial
    OPKO Health's Modex Therapeutics Begins MDX2301 Trial

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270045/0/en/OPKO-Health-s-ModeX-Therapeutics-Initiates-Clinical-Trial-of-MDX2301-for-the-Prevention-of-COVID-19.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Regeneron Pledges $1B+ For Modex Multispecific Antibodies
    Regeneron Pledges $1B+ For Modex Multispecific Antibodies

    29 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/regeneron-pledges-more-1b-biobucks-modex-multispecific-antibodies

    FIERCE BIOTECH
    29 Oct 2025
    Share Share
    OPKO Health's Modex Therapeutics Initiates MDX2004 Trial
    OPKO Health's Modex Therapeutics Initiates MDX2004 Trial

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175365/0/en/OPKO-Health-s-ModeX-Therapeutics-Begins-Clinical-Trial-of-MDX2004-for-the-Treatment-of-Advanced-Cancers.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    OPKO Health’s ModeX Therapeutics Forms Scientific Advisory Board
    OPKO Health’s ModeX Therapeutics Forms Scientific Advisory Board

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095774/0/en/OPKO-Health-s-ModeX-Therapeutics-Announces-Formation-of-Scientific-Advisory-Board-with-Leaders-at-the-Forefront-of-Immunology-and-Oncology-Drug-Development.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    ModeX And Merck Begin Phase 1 Epstein-Barr Virus Vaccine Study
    ModeX And Merck Begin Phase 1 Epstein-Barr Virus Vaccine Study

    07 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/07/3005382/0/en/OPKO-Health-s-ModeX-Therapeutics-Announces-Epstein-Barr-Virus-Vaccine-Candidate-Enters-Phase-I-Clinical-Study-in-Collaboration-with-Merck.html

    GLOBENEWSWIRE
    07 Jan 2025
    Share Share
    COVID antibodies shut down variants, earn $35M BARDA bucks
    COVID antibodies shut down variants, earn $35M BARDA bucks

    09 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/research/modexs-multispecific-antibodies-shut-down-covid-variants-and-advance-clinic-35m-more-barda

    FIERCE BIOTECH
    09 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search